Quent Capital, LLC Moderna, Inc. Transaction History

Quent Capital, LLC

$833 Million
Q1 2024

A detailed history of Quent Capital, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 406 shares of MRNA stock, worth $48,037. This represents 0.01% of its overall portfolio holdings.

Number of Shares

406

Previous 406 -0.0%

Holding current value

$48,037

Previous $43,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$85.37 - $115.44 $2,902 - $3,924	-34 Reduced 7.73%	406 $43,000
Q4 2023 Jun 14, 2024	SELL	$69.51 - $104.43 $3,336 - $5,012	-48 Reduced 9.84%	440 $43,000
Q4 2023 Jan 19, 2024	SELL	$69.51 - $104.43 $3,336 - $5,012	-48 Reduced 9.84%	440 $43,000
Q3 2023 Jun 14, 2024	BUY	$96.41 - $126.61 $2,217 - $2,912	23 Added 4.95%	488 $50,000
Q3 2023 Oct 10, 2023	BUY	$96.41 - $126.61 $2,217 - $2,912	23 Added 4.95%	488 $50,000

Q2 2023 Jun 14, 2024	SELL	$118.5 - $160.53 $7,821 - $10,594	-66 Reduced 12.43%	465 $56,000
Q2 2023 Jul 10, 2023	SELL	$118.5 - $160.53 $7,821 - $10,594	-66 Reduced 12.43%	465 $56,000
Q1 2023 Jun 14, 2024	BUY	$135.66 - $197.02 $16,957 - $24,627	125 Added 30.79%	531 $81,000
Q1 2023 Apr 05, 2023	BUY	$135.66 - $197.02 $2,984 - $4,334	22 Added 4.32%	531 $81,000
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $828 - $1,470	7 Added 1.39%	509 $0
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $10,035 - $16,505	85 Added 20.38%	502 $59,000
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $6,325 - $9,535	-54 Reduced 11.46%	417 $60,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $36,799 - $68,399	-291 Reduced 38.19%	471 $81,000
Q4 2021 May 12, 2022	BUY	$225.82 - $368.51 $4,742 - $7,738	21 Added 2.83%	762 $194,000
Q4 2021 Feb 28, 2022	BUY	$225.82 - $368.51 $167,332 - $273,065	741 New	741 $188,000

Others Institutions Holding MRNA

# of Institutions

1,039

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.

Account

Quent Capital, LLC Moderna, Inc. Transaction History